Background: Public health (PH) policymakers are encouraged to use evidence in the decision-making process. However, little is known about what types of evidence policymakers working in local settings prefer to use. This study aims to evaluate policymakers' needs and sources of information, at regional and local levels. Methods: An electronic survey with telephone follow-up was carried out among PH policymakers and evidence producers (n = 152) working in a large UK city. Respondents were asked which types of evidence they used regularly, found most useful and what were their main sources of information. Semi-structured interviews (n = 23) added were analysed quantitatively in addition to the categorical data generated by the survey. Results: Policymakers use a much greater range of evidence and information than is often indicated in the literature on evidence-based policy. Local data were by far the most used (n = 95%) and most valued (n = 85%) type of information, followed by practice guidelines. The main sources of information were Government websites (84%), followed by information obtained through personal contacts (71%), including PH professionals, council officers and politicians. Academics were rarely consulted and research evidence was rarely seen as directly relevant. Conclusions: Policymakers use a wider range of evidence types than previously discussed in the literature. Although local data were most valued by policymakers, results suggest that these were accessed through personal contacts, rather than specialized organizations. Systems to provide local high-quality evidence for PH policy should be supported. 
Introduction
P ublic health (PH) policymakers are routinely encouraged and expected to use evidence in decision making. National and international guidelines mandate policy actors to use evidence when developing policy. 1 Having access to useful evidence is said to be beneficial for policymakers, who are thereby informed about 'the benefits, harms and costs of interventions to promote, [in order to] protect or maintain the health of populations'. 2 Despite this positive political and rhetorical environment, however, most commentators assume that research is under-used and that evidence available to policymakers is weak. [3] [4] [5] Research activity in this area has therefore focused on exhorting academics to improve the evidence base, 4 through, i.e. developing comparable epidemiological indicators, 6 developing models of evidence use, 7 identifying barriers to the use of evidence by policymakers 8, 9 or identifying which types of academic evidence policymakers prefer to use. 10 Most studies assume that if barriers were overcome, use of research in policymaking would increasealthough there are dissenting voices. [11] [12] [13] This perception explains the growth of studies examining interventions to increase translation of research into practice; 14 using knowledge brokers, 15, 16 coproduction of research 17 or user involvement. 18 Despite this research activity, it is often unclear what is meant by 'evidence' or what types of information are used by policymakers. 5, 7 There is little evidence that better-quality evidence is more frequently used by policymakers nor that describing policy problems more accurately leads problems being taken more seriously. We do not know how much evidence policymakers use or prefer to use. Most studies in this area focus exclusively on evidence from research or evidence produced by academics. 19, 20 Similarly, most studies have solicited responses from people working within the health sector only 2 ; but for PH, the range of actors involved crosses local authorities, health, charities and the private sector. 21 Although there is some research about the preferences of policymakers at national levels, 22, 23 the main sources of data for local and regional policy are less clear. It is vital for anyone wishing to influence policy to understand these preferences, as national and international policies are contested, negotiated and implemented through local settings. 11 Therefore, this study aims to identify the main types of information and data used by policymakers in PH in the United Kingdom, including respondents at national, regional and local levels, and from sectors including health, academia, local government and elsewhere.
Methods
The study was carried out in the United Kingdom, with a focus on a large urban conurbation (Greater Manchester) to include local and regional policymakers, and national figureheads. This conurbation hosted (at the time of data collection) 10 local authorities and 10 related health policy organizations. The sampling frame included any respondent directly influencing PH policy at director or executive level within these regional organizations, both by making policy, or by providing evidence for policy. Respondents were considered to work within PH policy if active in gathering analysing or disseminating PH intelligence, developing or implementing policy, evaluating or delivering programmes. Organizational websites of the 10 local authorities, related National Health Service (UK NHS) bodies and other relevant organizations (local universities and health surveillance organizations) were used to generate a list of names of relevant job holders (including PH professionals, academics, council officers and PH intelligence staff among others) to sample. These were then recruited to the study via email as described later.
A cross-sectional survey design was used. National policymakers were represented in the sample as some respondents also had national responsibilities. The survey was sent to the sample (n = 152) with an introductory email and study information sheet. This was followed up by an email and a telephone call if actors did not respond.
The survey asked policymakers two questions about evidence use in PH policymaking. Respondents were asked to choose categorical answers with space for open-ended answers. This is an approach similar to that used in many other studies. [24] [25] [26] [27] Free-text answers were analysed together with the data gathered from interviews (see later). To identify frequently used and preferred information types, overall counts (number of times chosen) were produced for each categorical answer and normalized by the number of respondents overall.
To analyse the main sources of information, respondents were asked to rank the sources of information shown in table 1 (question 2) in order of frequency of use, using a rating scale from 1 to10 (1 was most frequently, 10 least). Respondents were free to choose as many as they felt appropriate. As such, not all scores from 1 to10 were necessarily used, with all sources of information not used given a 0 score. Non-parametric Wilcoxon rank order tests 28 were used to rank policymakers' preferences (table 3) . For each categorical answer, three summary scores were produced: (i) a popularity score (a count of the number of times chose), (ii) a rank sum score or how highly they were ranked by participants (calculated by summing the number and rank for each time the source was chosen) and (iii) a normalized overall ranking score (normalized by dividing the overall rank by the number of nominations).
Qualitative data were drawn from semi-structured interviews conducted with a sub-sample of the respondents (n = 23). Respondents were purposively sampled to provide representation from all sectors and as broad a range of roles as possible. The questions above were used as part of the topic guide. The data were selected from a thematic coding using NVivo 8. 29 All data coded as 'evidence used/preferred' were analysed using content analysis to identify types of information used and preferred, and sources of information-i.e. just to count the number of times these sources and types were mentioned. Further, more in-depth qualitative analysis was out of scope for this analysis.
Questions for both the interview and the questionnaire were derived from a systematic review of the literature. 8 This was piloted for accessibility in a similar population (n = 8 for questionnaire, n = 19 for interview plus questionnaire) in another city (Liverpool). They were recruited using the same approach as the main study, i.e. develop a sampling frame through examination of major organizations and selection of participants who work earlier director level in these organizations. The feedback was collated, and the wording of questions was changed for clarity on the basis of these results. Most participants found the questions easy to interpret, with extra detail added to the questionnaire about level of influence (regional, national or local), and freedom of responses (within/outwith own organization or central government). This study was presented to local university and NHS ethics boards and considered not to require ethical approval.
Results
Responses were received from 123 actors (response rate 80.9%). Twenty-six actors declined, 15 had left their job, their employer had ceased to exist or were otherwise unreachable. Eighty-two responses were useable (54%), as others contained missing data or incomplete answers. The sample included directors of PH, local authority and primary care trust chief executives, council leaders and officers, PH intelligence staff, academics and third sector service providers; national, regional and city-level PH policymakers involved in the PH process within Greater Manchester (GM). The sample was split between UK NHS and NHS-associated bodies (n = 28), PH intelligence organizations (n = 13), local authorities (n = 29), third sector organizations (n = 9) and other (n = 2). Interviewees were drawn from all sectors (n = 23, 27 interviews requested, response rate 85%). Useable response rate by category is shown later (table 2) .
Policymakers were asked which type of information or evidence they most frequently used and what were the most useful types of information or evidence (figure 1). In both categories, local data were the most frequently cited type of evidence (95% and 80% of respondents, respectively). Examples of local data from the semistructured interviews ranged from standard surveillance data (morbidity and mortality) (n = 6) to service provision data (n = 5), to complex models of patient flows (n = 1) and integrated health and social care records (n = 2). The second most cited source of evidence was the joint strategic needs assessments, selected by 89% as 'frequently used'. These were statutory reports produced by local organizations reporting on health needs and behaviours of the local population. These rely on locally collected and analysed population data from health surveys and service access data. Other types of local data mentioned during the interviews were public views, knowledge of local personalities and leadership and tacit knowledge. Also mentioned by interviewees were views of local residents and service users, including public informant groups (e.g. Citizen's Jury).
Research-derived evidence was considered useful and used by most participants, especially qualitative research studies and survey data. Systematic review and trial data were also used (47% and 23%, respectively) but were much less popular.
Two respondents also mentioned evidence summaries or reviews, and Cochrane reviews specifically. Most interviewed actors, however, did not use them and similarly also did not use meta-analyses. In a number of cases (n = 3), meta-analyses were not used because the respondents were not aware of what these were.
Survey data and PH surveillance data were both more 'used' than that they were considered to be 'useful'. Several respondents (n =
Respondents were also asked if there were other types of regularly used evidence not mentioned in the closed categories. Answers provided included professional advice, political and local 'soft' information from 'the field'-meaning knowledge of local personalities, local systems and organizations. Policymakers described a lack of capacity for analysis, and wanting assistance with analysing local data in more sophisticated ways; for instance to model care pathways to understand what works for different groups; to understand the interplay of local factors and roles of different actors at points in the care pathway; to understand crosssector and cross-governmental department interventions and how to use more active and rigorous audit loops so that ineffective interventions could be halted. However, the main potential improvement identified, which was put forward by 31% of interviewed actors, would be improved interpretations of existing data. It was considered desirable to have reliable experts explain the importance of reports, translate the data into comprehensible statements and provide clear directions for decision makers.
Sources of evidence
The most frequently mentioned sources were governmental websites (84%), followed by National Institute for Health and Care (NICE) guidelines (70%). 'Experts' and 'other people' were both chosen by over 70% of respondents, with 'Experts' ranked 4th and other people 7th-in other words, ranked low but chosen by nearly every respondent (82%). Table 3 describes how frequently each source was chosen, and how it was ranked by participants.
Identifying sources of information from the qualitative data revealed a slightly different picture. Most people named organizations (e.g. NICE, Strategic Health Authorities, the Audit Commission, the National Treatment Agency and various charities), knowledge transfer initiatives (professional networks and knowledge exchange partnerships), the media, industry or meetings. Annual local reports produced by PH professionals were also mentioned. Four interviewees described 'personal experience' as a source of information and evidence.
Twenty-nine respondents (23 interviewees and 6 from the freetext answers from the questionnaire) named specific individuals or job roles as sources of information in the qualitative data. Answers in this category included roles such as 'director of PH' or 'local PH Figure 1 Types of information or evidence regularly used/considered most useful by policy actors (percentage of respondents) 
Discussion
This study aimed to identify what types of evidence and information policymakers frequently use and prefer, and to identify the main sources for such evidence. Local data, including epidemiological, historical, qualitative and interpersonal information, is most valued by PH policymakers, but a wide range of evidence types are used beyond academic researchderived findings. The similarities between 'regularly used' and 'most preferred' evidence may indicate that overall, policymakers feel that their evidence needs are broadly met, although several suggestions for improved analysis of existing data were made. Experimental trial data and subsequent distillation in systematic reviews and metaanalyses, and more qualitative research, were all reported to be 'more useful' than 'regularly used'. Personal and political information were described as more influential, on a day-to-day basis, than research evidence by most policymakers. This is somewhat surprising, given the emphasis on quantitative data from (randomized) clinical trials, systematic reviews and meta-analyses as more reliable and rigorous types of evidence. 20 'Other people' came out as the most frequently cited source of evidence when results from the survey and qualitative interviews were combined. This is particularly interesting given the amount research on webbased knowledge translation tools by the PH community. Policymakers indicated they consult colleagues as often as they use NICE and intelligence websites and that experts were a valued source of evidence. However, it remains unclear who these experts wereand it is likely that their advice would differ. Some policymakersthose who make decisions-may rely on analysts and civil servants, who can filter the evidence to suit the policy in hand. [30] [31] [32] [33] [34] 39, 40 One possible source of bias is that senior staff may rely on junior staff to collate information for them. If so, this suggests that the role of individuals in knowledge translation should be properly evaluated, through, e.g. knowledge brokerage evaluations. Murray and Lopez 4 suggests that better information is needed to give validity to the claims of PH advocates; a role which, for him, should be filled by 'scientists'-rather than 'media consultants'. However, knowledge translation interventions by, i.e. health advocates or knowledge brokers have not been shown to have an effect on policy. 16 Although data indicate that interpersonal relationships are clearly important in the evidence-policy cycle, [32] [33] [34] only a few studies have actually gathered data on these individual connections. This relational data could be gathered using a network approach. 34 This contradicts commonly held assumptions from the academic community that PH policymakers do not use evidence. 5, 8, 9 -as do the complex and sophisticated questions (such as interplay of factors across policy domains) proposed by policymakers. Most studies in this area focus on evidence from research or evidence produced by academics. 19, 20 The findings of this study indicate that policymakers are aware of the substantive agenda they are required to address, and therefore they do not need more descriptions of population health problems. Indeed, too much information can lead to 'paralysis by analysis'-describing the problem in ever-more sophisticated ways does not help policymakers develop strategies or solutions but overwhelms them with unwanted data. 35 Exploitation of existing datasets through more sophisticated analytical techniques would answer the needs of policymakers and academics alike.
Corroborating previous studies, universities were only mentioned by one person as a source of evidence and individual researchers rarely. 32, 36 Although this may suggest that academic research is not always directly relevant, several of the evidence-types reported (e.g. NICE guidelines) may draw on or be informed by academic evidence. The supposed weakness of the evidence base (in academic terms) may not therefore be to blame for perpetual health inequalities. It is in the interest of academic researchers to indicate the necessity of more research and the directions of new research. As Fuller 37 states '[P]oliticians can capitalise on the endless ingenuity displayed by scientists -both natural and social -in adapting their research agendas to suit the needs of potential clients, so as to feed their own endless needs for funds. Moreover, the natural tendency of scientists to want to examine things more comprehensively, in greater detail and, of course, with an eye towards a renewal of their contract, nicely plays into politicians own propensity to temporize, whenever possible. Never have the worst character traits of two groups worked to such mutual advantage'. (p. 136).
Limitations
This study has a number of limitations. The overall number of respondents is relatively small, as the sampling frame itself was necessarily small. In addition, we achieved a relatively high response rate from our source population (80%) compared with other surveys (55%, SD 19) . 38 Incomplete data (e.g. a partially completed survey) affected the results by lowering this response rate, however. Few NHS chief executives responded, limiting our ability to generalize about decision makers, and the representativeness of these findings for local and national populations across Europe is questionable. Moreover, because of the rapid reorganization of health providers at the time, it is likely that some potential respondents were not included in the initial sampling frame. However, high levels of response were achieved from their advisors, and the results are supported by other literature in the area. 8 The focus on local data may reflect the sample, which was drawn from regional and local organizations. Decision makers at this level may find data pertaining to their local populations more useful for managing resources. There are some differences between the survey and interview data, probably due to the open-ended nature of the discussion. However, the same questions were used as prompts for the interviews as in the survey, and thus the data are still comparable.
Conclusions and implications
We have shown that policymakers use a wide range of different sources to obtain information, but they indicate they do not use research evidence directly. As such, further descriptive studies (as proposed by, e.g. Murray and Lopez 4 ) to develop health indicators may not represent the next step forwards in translation of research in to PH policy. Instead, researchers may find a more fruitful approach is to build their own relationships with policymakers both locally and nationally to enable direct transfer from research data into policy. This study contributes to our understanding of data need at local and regional levels and emphasizes the importance of local, routinely collected data, also highlighted in a recent systematic review. 8 If local data are valued more than research evidence, the identification and analysis of these, which have largely fallen beneath the academic radar, offers an exciting opportunity for researchers to collaborate with local policymakers-already grasped by several PH knowledge translations organizations in the United Kingdom (e.g. FUSE, www. fuse.ac.uk, the Glasgow Centre for Population Health, www.gcph.co. uk)-to mutual benefit. The sophistication of policymakers' suggestions for analysis of data should indicate the potential benefits to policymakers, academics and the wider population in enabling knowledge exchange to occur more easily.
